Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia - A clinical research center study

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 10, 1996, Pages 3604-3606

  Van Der Poll, Tom ^b   Barber, Annabel E ^b   Coyle, Susette M ^b   Lowry, Stephen F ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GLUCOCORTICOID; HYDROCORTISONE; INTERLEUKIN 10; TUMOR NECROSIS FACTOR;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ENDOTOXEMIA; HUMAN; HUMAN EXPERIMENT; HYPERCORTISOLISM; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STRESS;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXEMIA; EPINEPHRINE; ESCHERICHIA COLI; FEMALE; HUMANS; HYDROCORTISONE; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MALE; TUMOR NECROSIS FACTOR-ALPHA;

ESCHERICHIA COLI;

EID: 0029842527     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.10.3604     Document Type: Article

References (16)

1. Moore KW, O'Garra A, de Waal malefyt R, Vieira P, Mosmann TR. 1993 Interleukin 10. Annu Rev Immunol. 11:165-190.
2. De Waal Malefyt R, Abrams J, Bennett B, Figdor C, de Vries JE. 1991 IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 174:1209-1220.
3. Fiorentine DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. 1991 IL-10 inhibits cytokine production by activated macrophages. J Immunol. 147:3815-3822.
4. Howard M, Muchamuel T, Andrade S, Menon S. 1993 Interleukin 10 protects mice from lethal endotoxemia. J Exp Med. 177:1205-1208.
5. Gérard C, Bruyns C, Marchant A, et al. 1993 Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med. 177:547-550.
6. Marchant A, Bruyns C, Vandenabeele P, et al. 1994 IL-10 controls IFN- and TNF production during experimental endotoxemia. Eur J Immunol. 24:1167-1171.
7. Standiford TJ, Strieter RM, Lukacs NW, Kunkel SL. 1995 Neutralization of IL-10 increases lethality in endotoxemia. Comparative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J Immunol. 155:2222-2229.
8. Van der Poll T, Marchant A, Buurman WA, et al. 1995 Endogenous interleukin 10 protects mice from death during septic peritonitis. J Immunol. 155:5397-5401.
9. Frayn KN. 1986 Hormonal control of metabolism in trauma and sepsis. Clin Endocrinol (Oxf). 24:577-599.
10. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A. 1986 Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science. 232:977-980.
11. Severn A, Rapson NT, Hunter CA, Liew FY. 1992 Regulation of tumor necrosis factor production by adrenaline and β-adrenergic agonists. J Immunol. 148:3441-3445.
12. Van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF. 1996 Epinephrine inhibits tumor necrosis factor and potentiates interleukin 10 production during human endotoxemia. J Clin Invest. 97:713-719.
13. Barber AE, Coyle SM, Marano MA, et al. 1993 Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol. 150:1999-2006.
14. Santos AA, Scheltinga MR, Lynch E, et al. 1993 Elaboration of interleukin 1-receptor antagonist is not attenuated by glucocorticoids after endotoxemia. Arch Surg. 128:138-144.
15. Barber AE, Coyle SM, Fischer E, et al. 1995 Influence of hypercortisolemia on soluble TNF receptor II and interleukin-1 receptor antagonist responses to endotoxin in human beings. Surgery. 118:406-411.
16. Arzt E, Sauer J, Pollmacher T, et al. 1994 Glucocorticoids suppress interleukin-1 receptor antagonist synthesis following induction by endotoxin. Endocrinology. 134:672-677.